Keywords: USA, FDA, Statains, Cholesterol lowerers, Warning labels, Cognitive effects, Diabetes

FDA expands on cholesterol-lowering drug risks

Article | 29 February 2012

Print This

Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins were announced yesterday by the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in